European Journal of Epidemiology

, Volume 23, Issue 1, pp 11–15

Incidence of lymphohaematopoietic cancer at a university laboratory: a cluster investigation

  • Petter Kristensen
  • Bjørn Hilt
  • Kristin Svendsen
  • Tom K. Grimsrud
CANCER

Abstract

We investigated a suspected cluster of lymphohaematopoietic cancer in departments of biology and chemistry at a Norwegian university. A historical cohort of students and employees (n = 7,189) were followed for cancer for 96,936 person-years in the Cancer Registry of Norway. Overall, 12 cases of lymphohaematopoietic cancer were identified, which was close to the expected number (standardised incidence ratio 1.1, 95% confidence interval (CI) 0.6–1.9). The SIR for leukaemia was 1.8 (95% CI 0.6–4.2) whereas incidences for non-Hodgkin lymphoma and Hodgkin’s disease incidence were close to the expected. Distinct rate differences were observed in subgroups, and the strongest adjusted associations were found for Ph.D. students (rate ratio (RR) = 4.8, 95% CI 1.1–20.3) and students who participated in basic organic chemistry laboratory course (RR = 4.4, 95% CI 1.2–18.8). The latter category was identified a priori because it was the only student activity with known use of benzene according to the university administration. This is an observational study with some limitations, and hence, caution is warranted when drawing inferences on the causal relationship between university activities and cancers under study. The study provides an example that cluster investigations can answer questions of public importance despite a more limited value regarding causal inference.

Keyword

Benzene Cluster Fixating agents Laboratory Leukaemia Lymphoma 

References

  1. 1.
    International Programme on Chemical Safety (IPCS). Selected radionuclides. Environmental Health Criteria 25. Geneve: WHO; 1983. p. 198.Google Scholar
  2. 2.
    International Programme on Chemical Safety (IPCS). Benzene. Environmental Health Criteria 150. Geneve: WHO;1993. p. 113–4.Google Scholar
  3. 3.
    United Nations Scientific Committee on the Effects of Atomic Radiation, UNSCEAR. Sources and effects of ionizing radiation: UNSCEAR 2000 report to the General Assembly, with scientific annexes. Volume II: Effects. New York: United Nations; 2000. p. 343–52. http://www.unscear.org/docs/reports/annexi.pdf. Accessed 20 September 2007.
  4. 4.
    Snyder R. Benzene and leukemia Crit Rev Toxicol 2002;32:155–210.PubMedCrossRefGoogle Scholar
  5. 5.
    Glass DC, Gray CN, Jolley DJ, et al. Leukemia risk associated with low-level benzene exposure. Epidemiology 2003;14:569–77.PubMedCrossRefGoogle Scholar
  6. 6.
    Hayes RB, Yin SN, Dosemeci M, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese academy of preventive medicine-national cancer institute benzene study group. J Natl Cancer Inst 1997;89:1065–71.PubMedCrossRefGoogle Scholar
  7. 7.
    Rachet B, Partanen T, Kauppinen T, et al. Cancer risk in laboratory workers: an emphasis on biological research. Am J Ind Med 2000;38:651–65.PubMedCrossRefGoogle Scholar
  8. 8.
    Savitz DA, Andrews KW. Review of epidemiologic evidence on benzene and lymphatic and hematopoietic cancers. Am J Ind Med 1997;31:287–95.PubMedCrossRefGoogle Scholar
  9. 9.
    Golden R, Pyatt D, Shields PG. Formaldehyde as a potential human leukemogen: an assessment of biological plausibility. Crit Rev Toxicol 2006;36:135–53.PubMedCrossRefGoogle Scholar
  10. 10.
    Lynge E, Anttila A, Hemminki K. Organic solvents and cancer. Cancer Causes Control 1997;8:406–19.PubMedCrossRefGoogle Scholar
  11. 11.
    Andersen A, Barlow L, Engeland A, et al. Work-related cancer in the Nordic countries. Scand J Work Environ Health 1999;25(suppl 2):1–116.PubMedGoogle Scholar
  12. 12.
    Directorate for Health and Social Affairs. The challenge of the gradient. Oslo: Directorate for Health and Social Affairs; 2005. p. 11.http://www.shdir.no/gradienten/publikasjoner/the_challenge_of_the_gradient__ndash__the_norwegian_directorate_for_health_and_social_affairs_rsquo__plan_of_action_to_reduce_social_inequalities_in_health_19770. Accessed 20 September 2007.
  13. 13.
    Armstrong BG. Comparing standardized mortality ratios. Ann Epidemiol 1995;5:60–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Rothman KJ. A sobering start for the cluster busters’ conference. Am J Epidemiol 1990;132(suppl 1):S6–13.PubMedGoogle Scholar
  15. 15.
    Quataert PK, Armstrong B, Berghold A, et al. Methodological problems and the role of statistiscs in cluster response studies: a framework. Eur J Epidemiol 1999;15:821–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Goujard J. Clusters of birth defects: emergency and management. A review of some publications. Eur J Epidemiol 1999;15:853–62.PubMedCrossRefGoogle Scholar
  17. 17.
    Caldwell GG. Twenty-two years of cancer cluster investigations at the centers for disease control. Am J Epidemiol 1990;132(suppl 1):S43–7.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2007

Authors and Affiliations

  • Petter Kristensen
    • 1
    • 2
  • Bjørn Hilt
    • 3
    • 4
  • Kristin Svendsen
    • 3
    • 5
  • Tom K. Grimsrud
    • 6
  1. 1.National Institute of Occupational HealthOsloNorway
  2. 2.Faculty of Medicine, Section for Preventive Medicine and EpidemiologyUniversity of OsloOsloNorway
  3. 3.Department for Occupational Medicine St. Olav’s University HospitalTrondheimNorway
  4. 4.Faculty of Medicine, Department of Cancer Research and Molecular MedicineThe Norwegian University of Science and Technology (NTNU)TrondheimNorway
  5. 5.Faculty of Social Sciences and Technology Management, Department of Industrial Economy and Technology ManagementThe Norwegian University of Science and Technology (NTNU)TrondheimNorway
  6. 6.Cancer Registry of NorwayOsloNorway

Personalised recommendations